VNDA — Vanda Pharmaceuticals Inc. stock price, charts and financials

QT39Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.33
+0.10+1.91%
OverviewShort InterestFilings
VNDAQT39Vanda Pharmaceuticals Inc.·NASDAQ
5.33+1.91%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20263Initial statement of beneficial ownership
Jun 05, 20268-KCurrent report
Jun 05, 2026S-8Registration of employee benefit securities
May 20, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
May 05, 2026EFFECTNotice of effectiveness
Apr 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 24, 20264Statement of changes in beneficial ownership
Apr 24, 20263Initial statement of beneficial ownership
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026ARSAnnual report to shareholders
Apr 22, 20268-KCurrent report
Apr 13, 20263Initial statement of beneficial ownership
Apr 13, 20263Initial statement of beneficial ownership
Apr 02, 20268-KCurrent report
#1 / 25 of 263
Page
▼
/ 11